AMGN vs BMY
Amgen Inc. · Bristol-Myers Squibb Company
Relative return (rebased to 100)
Key stats
| Metric | AMGN | BMY |
|---|---|---|
| Price | $407.44 | $59.58 |
| Market Cap | $220.28B | $121.70B |
| P/E | 28.57 | 17.25 |
| P/B | 18.85 | 5.45 |
| P/S | 5.99 | 2.53 |
| ROE | 66.0% | 31.6% |
| Net Margin | 21.0% | 14.6% |
| Gross Margin | — | 63.8% |
| Revenue Growth | 10.0% | -0.2% |
| Dividend Yield | 2.37% | 4.18% |
| EPS | $14.26 | $3.45 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.